Top

Current Treatment Options in Oncology

Published in:

01-08-2003

Parathyroid tumors

Authors: Tobias Carling, MD, PhD, Robert Udelsman, MD, MBA

Published in: Current Treatment Options in Oncology | Issue 4/2003

Title: Parathyroid tumors
Authors: Tobias Carling, MD, PhD
Robert Udelsman, MD, MBA
Publication date: 01-08-2003
Publisher: Current Medicine Group
Published in: Current Treatment Options in Oncology / Issue 4/2003
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-003-0007-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2003

Mantle cell lymphoma

Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas

Insulinoma

MALT lymphomas

Nonmyeloablative transplantation for lymphoma

Pheochromocytoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer